Management of tinea capitis. A status report.
Tinea capitis is the most common pediatric fungal infection, usually affecting school-age children. It is caused by a dermatophyte from the genus Trichophyton or Microsporum. The predominant pathogens vary according to geographic location. Infection rates are higher in urban regions, especially those with overcrowded living conditions. In the United States, the incidence is highest among African-American children and appears to be significantly lower among Asian Americans. Tinea capitis may persist into adulthood, especially in females with Trichophyton tonsurans infection. Tinea capitis also has been reported in neonates, infants, and elderly patients.
Del Rosso
J Q
JQ
University of Nevada School of Medicine, Las Vegas, USA.
Gupta
A K
AK
D000284:Administration, Oral; D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D002353:Carrier State; D002648:Child; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use*; D009281:Naphthalenes / Q000627:therapeutic use*; D000077291:Terbinafine; D014006:Tinea Capitis / Q000175:diagnosis / Q000188:drug therapy*
D000935:Antifungal Agents; D009281:Naphthalenes; D017964:Itraconazole; D000077291:Terbinafine